IDH1 and cancer: The recent discovery that genes encoding IDH-1/2 are recurrently mutated in several cancers, which induce a neomorphic enzyme activity that results in the production of the oncometabolite (R)-2HG, unveiled a fascinating and complex biology behind the dysregulation and functional consequences of metabolites in cancers29.